I don't know what 'facts' you are referring to, but this is the 12-month pps movement on PPH:
Last Trade: 64.92
52wk Range: 49.28 - 70.18
..and XPH:
Last Trade: 38.80
52wk Range: 23.60 - 40.89
...and PFE:
Last Trade: 17.69
52wk Range: 11.62 - 20.36
Is this the 'instability' you were suggesting is responsible for Cor not achieving a partnership?
Late development...Now I see it is the PhIIb RD trial design fears that may have kept a partnership away. It only took 17 months to 'design' that excuse. Gfp, Neuro, job well done!
Who'd a thought these pharma leaders would be so driven by fear. Fear trumps greed. Greed trumps truth. Truth trumps.....
Market Data 
Markets 
AI
